Light chain multiple myeloma: Definition, diagnosis, and outlook
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases - ScienceDirect
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma | Blood Cancer Journal
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
The Proximal Tubule Toxicity of Immunoglobulin Light Chains - Kidney International Reports
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
Light Chain Multiple Myeloma: Your Ultimate Guide | MyMyelomaTeam
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
The Answer, My Friend, is Flowing in the Blood: How to Monitor Treatment Response in Myeloma
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Frontiers | High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
Living With - HealthTree for Myeloma
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
Kappa and Lambda Light Chains - HealthTree for Myeloma
